Interferon alpha-2b biosimilar (Intas Biopharmaceuticals)

干扰素α-2b生物类似药 (Intas Biopharmaceuticals)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha-2b biosimilar (Intas Biopharmaceuticals)

Drug Alias Name干扰素α-2b生物仿制药 (Intas Biopharmaceuticals)Recombinant interferon alpha-2b (Intas Biopharmaceuticals)重组人干扰素α-2b生物仿制药 (Intas Biopharmaceuticals)Intalfa

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsNeoplasmsHepatitis CHepatitis B

Global Approved IndicationsNeoplasmsHepatitis CHepatitis B

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2007/01/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesIntas Biopharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesIntas Biopharmaceuticals

Inactive CompaniesN/A

Active IndicationsNeoplasmsHepatitis CHepatitis B

Inactive IndicationsN/A

Other Information

ATC CodeL03AB05